A prognostic signature based on adenosine metabolism related genes for ovarian cancer

A prognostic signature based on adenosine metabolism related genes for ovarian cancer

BackgroundOvarian cancer is one of the most common cause of cancer death in women due to its late diagnosis and susceptibility to drug resistance. Adenosine (ADO) signaling plays a key role in immune activity and tumor progression. In this study, we constructed a signature of ADO metabolism related...

Full description

Bibliographic Details
Main Authors:	Weifeng Liang, Chao Zhou, Jingshu Wang, Jing Zhao, Fang Liu, Guoqiang Wang, Chunwei Xu, Yuzi Zhang, Wenxian Wang, Shangli Cai, Yusheng Han, Lei Chang, Peihai Zhang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-11-01
Series:	Frontiers in Oncology
Subjects:	adenosine metabolism ovarian cancer gene expression prognostic analysis signature
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2022.1003512/full

Similar Items

Suppressive stroma-immune prognostic signature impedes immunotherapy in ovarian cancer and can be reversed by PDGFRB inhibitors
by: Dong Yang, et al.
Published: (2023-09-01)

Identification of a glycolysis‐related gene signature for survival prediction of ovarian cancer patients
by: Dai Zhang, et al.
Published: (2021-11-01)

An Immune-Related Gene-Based Signature as Prognostic Tool in Ovarian Serous Cystadenocarcinoma
by: Shi F, et al.
Published: (2021-07-01)

Dynamic TF-lncRNA Regulatory Networks Revealed Prognostic Signatures in the Development of Ovarian Cancer
by: Qiuyan Guo, et al.
Published: (2020-05-01)

A Novel pyroptosis-related signature for predicting prognosis and evaluating tumor immune microenvironment in ovarian cancer
by: Jiani Yang, et al.
Published: (2023-09-01)

Development of a multi-gene-based immune prognostic signature in ovarian Cancer
by: Tiefeng Cao, et al.
Published: (2021-01-01)

Identification of a Prognostic Signature Associated With DNA Repair Genes in Ovarian Cancer
by: Hengzi Sun, et al.
Published: (2019-09-01)

Identification of NAD+ Metabolism-Derived Gene Signatures in Ovarian Cancer Prognosis and Immunotherapy
by: Liang Lin, et al.
Published: (2022-06-01)

A lactate metabolism-related signature predicting patient prognosis and immune microenvironment in ovarian cancer
by: Linhua Zhu, et al.
Published: (2024-03-01)

Anoikis-related signature predicts prognosis and characterizes immune landscape of ovarian cancer
by: Jiani Yang, et al.
Published: (2024-02-01)

Identification and Validation of a Novel Prognostic Signature Based on Ferroptosis-Related Genes in Ovarian Cancer
by: Zhe Cheng, et al.
Published: (2023-01-01)

CD4+ conventional T cells-related genes signature is a prognostic indicator for ovarian cancer
by: Tian Hua, et al.
Published: (2023-03-01)

A cuproptosis-related signature predicts prognosis and indicates cross-talk with immunocyte in ovarian cancer
by: Bikang Yang, et al.
Published: (2024-05-01)

Establishment of a novel glycolysis-related prognostic gene signature for ovarian cancer and its relationships with immune infiltration of the tumor microenvironment
by: Jianlei Bi, et al.
Published: (2021-09-01)

Novel Model for Comprehensive Assessment of Robust Prognostic Gene Signature in Ovarian Cancer Across Different Independent Datasets
by: Zhitong Bing, et al.
Published: (2019-10-01)

A novel autophagy-related gene signature associated with prognosis and immune microenvironment in ovarian cancer
by: Jiani Yang, et al.
Published: (2023-04-01)

A Potential Immune-Related Long Non-coding RNA Prognostic Signature for Ovarian Cancer
by: Xue Pan, et al.
Published: (2021-07-01)

A macrophage related signature for predicting prognosis and drug sensitivity in ovarian cancer based on integrative machine learning
by: Bo Zhao, et al.
Published: (2023-10-01)

A prognostic model based on immune-related long noncoding RNAs for patients with epithelial ovarian cancer
by: Yao Peng, et al.
Published: (2022-01-01)

ANXA2P2: A Potential Immunological and Prognostic Signature in Ovarian Serous Cystadenocarcinoma via Pan-Carcinoma Synthesis
by: Yanna Zhang, et al.
Published: (2022-02-01)

Identification and validation of an immune-related lncRNAs signature to predict the overall survival of ovarian cancer
by: He Li, et al.
Published: (2022-10-01)

Adenosine Inhibits Ovarian Cancer Growth Through Regulating RhoGDI2 Protein Expression
by: Xia B, et al.
Published: (2019-11-01)

Development of a prognostic gene signature for hepatocellular carcinoma
by: Cuiyun Wu, et al.
Published: (2022-01-01)

Construction of a prognostic signature for serous ovarian cancer based on lactate metabolism-related genes
by: Jiangdong Xiang, et al.
Published: (2022-09-01)

Identification of a Prognostic Signature for Ovarian Cancer Based on Ubiquitin-Related Genes Suggesting a Potential Role for FBXO9
by: Xiaomei Luo, et al.
Published: (2023-11-01)

Towards a potential pan-cancer prognostic signature for gene expression based on probesets and ensemble machine learning
by: Davide Chicco, et al.
Published: (2022-11-01)

Development and verification of a 7-lncRNA prognostic model based on tumor immunity for patients with ovarian cancer
by: Jing Feng, et al.
Published: (2023-02-01)

Development of a Prognostic Five-Gene Signature for Diffuse Lower-Grade Glioma Patients
by: Qiang Zhang, et al.
Published: (2021-07-01)

Construction and validation of a transcription factors-based prognostic signature for ovarian cancer
by: Qingyuan Cheng, et al.
Published: (2022-02-01)

Identification of an Individualized Prognostic Biomarker for Serous Ovarian Cancer: A Qualitative Model
by: Fengyuan Luo, et al.
Published: (2022-12-01)

Prognostic Cancer Gene Expression Signatures: Current Status and Challenges
by: Yuquan Qian, et al.
Published: (2021-03-01)

Analysis of Autophagy-Related Signatures Identified Two Distinct Subtypes for Evaluating the Tumor Immune Microenvironment and Predicting Prognosis in Ovarian Cancer
by: Xingyu Chen, et al.
Published: (2021-05-01)

Molecular subtypes, clinical significance, and tumor immune landscape of angiogenesis-related genes in ovarian cancer
by: Haixia Tang, et al.
Published: (2022-08-01)

Machine learning developed a CD8+ exhausted T cells signature for predicting prognosis, immune infiltration and drug sensitivity in ovarian cancer
by: Rujun Chen, et al.
Published: (2024-03-01)

Identification and validation of a five-gene prognostic signature based on bioinformatics analyses in breast cancer
by: Xin-jie Du, et al.
Published: (2023-02-01)

Dynamic changes in serum adenosine and the adenosine metabolism-based signature for prognosis in HER2-positive metastatic breast cancer patients
by: Lijun Wang, et al.
Published: (2024-12-01)

Identification and validation of a disulfidptosis-related genes prognostic signature in lung adenocarcinoma
by: Yanpeng Zhang, et al.
Published: (2024-01-01)

A signature based on anoikis-related genes for the evaluation of prognosis, immunoinfiltration, mutation, and therapeutic response in ovarian cancer
by: Yiqi Duan, et al.
Published: (2023-06-01)

ADENOSINE DEAMINASE ACTIVITY AND SERUM C-REACTIVE PROTEIN AS PROGNOSTIC MARKERS OF CHAGAS DISEASE SEVERITY
by: Iván Darío BRAVO-TOBAR, et al.
Published: (2015-10-01)

Identification of STEAP3-based molecular subtype and risk model in ovarian cancer
by: Zouyu Zhao, et al.
Published: (2023-06-01)